
Revvity (RVTY): Recovery Story Meets Rich Valuation
Revvity is showing a real earnings recovery, led by strong Diagnostics growth and improving Life Sciences momentum. But the stock already reflects much of that progress, with leverage and valuation keeping the rating at Hold.



